Navigation Links
U of M researchers using salmonella to fight cancer
Date:3/9/2011

MINNEAPOLS / ST. PAUL (March 9, 2011) University of Minnesota researchers are using salmonella the bacteria commonly transmitted through food that sickens thousands of U.S. residents each year to do what was once unthinkable: help people.

U of M Masonic Cancer Center researchers believe salmonella may be a valuable tool in the fight against cancer in organs surrounding the gut such as the liver, spleen, and colon since that's where salmonella naturally infects the body.

Researchers want to "weaponize" salmonella, allowing the bacteria to then attack cancer cells in its natural environment.

Trials in animals have already shown salmonella can successfully controlled tumors in the gut. Human clinical trials are already underway at the U of M and are showing promise.

"Many bacteria and viruses - even harmful ones - can be used to fight disease," said Edward Greeno, M.D., lead researcher on the clinical study and Medical Director of the Masonic Cancer Clinic. "We believe it may even be possible to use bacteria to fight cancer."

Scientists have known for centuries that cancer patients sometimes get better after they've been exposed to an infection. For example, Greeno said, there is a published Austrian report from the 1860's on a patient with a large tumor. The patient was placed in the same room as another sick patient with a bad infection. Soon, the tumor became infected and began to shrink in the original patient and nearly disappeared.

Unfortunately, the infection also killed the patient with the tumor.

So the key for this research initiative, Greeno said, was to find a way to get the tumor fighting abilities of salmonella delivered to the patient - without making the patient sick.

What they came up with:

  • Greeno's Medical School colleague, Dan Saltzman, M.D., Ph.D., genetically modified a batch of salmonella to weaken it and added Interlueken 2, or IL-2. "You could think of IL-2 as a guard dog that sniffs around looking for threats inside the body." he said. When it finds one, it calls in an attack by the immune system.
  • Researchers knew if they could make IL-2 near tumors, it would identify the cancerous cells as a threat and trigger an immune response near the tumor.
  • Salmonella naturally finds its way to a person's gut and associated tissues. Salmonella also naturally likes to grow inside of tumor cells. Hence, if you're looking for ways to treat cancer in the bowels, the nearby lymph nodes or the liver - salmonella is a perfect method to deliver a package of IL-2.

In a nutshell, by using genetically modified salmonella packaged with IL-2, Medical School researchers have created a kind of two-prong attack on cancer the immune response called in by IL-2, and the salmonella itself. The therapy is administered simply mixed with a few ounces of water and imbibed orally.

"This probably won't replace other ways of treating cancer such as chemotherapy and radiation," Greeno said. "But it's a promising area of study and we hope it can be a potent tool in our battle against cancer. It also has potential to be a much cheaper and less toxic alternative to chemotherapy and radiation."


'/>"/>

Contact: Nick Hanson
hans2853@umn.edu
612-624-2449
University of Minnesota
Source:Eurekalert

Related medicine news :

1. University of South Florida researchers find blood-brain barrier damaged by disease
2. Boston researchers create SMArt platform architecture, launch $5,000 health app competition
3. UCLA researchers use nano-Velcro technology to improve capture of circulating cancer cells
4. Aging in place preserves seniors independence, reduces care costs, MU researchers find
5. Elderly see pedestrians half as often as younger drivers, according to Ben-Gurion U. researchers
6. Researchers use human cues to improve computer user-friendliness
7. Researchers find new mechanism behind the formation and maintenance of long-term memories
8. Researchers pinpoint genetic pathways involved in breast cancer
9. Penn researchers find new role for cancer protein p53
10. UCSF researchers uncover hormone pathway to fatty liver disease
11. Researchers pinpoint patients who receive greatest benefit from heart failure treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... Lewisville, TX (PRWEB) , ... September 19, 2017 , ... ... in the United States, named Dr. Howard Ng, as the new Medical Director of ... will be the new facility Medical Director of our Pflugerville- FM 685 location,” said ...
(Date:9/19/2017)... ... 2017 , ... When it comes to household safety, there are few priorities ... to keep babies and toddlers safe, and there's no better time for companies to ... to Check Labels, Brands that sell all kinds of common consumer products should spend ...
(Date:9/19/2017)... ... September 19, 2017 , ... With Netmail ... contractors in the United States, can easily manage all of their data, apply ... on premise platforms simultaneously. “As a construction company,” says Ryan Sinnwell, the Infrastructure ...
(Date:9/18/2017)... ... , ... A September 7 article on BBC News describes new ... world’s most common and least expensive medications, may be able to stimulate stem cells ... California Dental Group and Calabasas Dental Care says that, while it’s likely to be ...
(Date:9/18/2017)... ... September 18, 2017 , ... Allegheny Health Network’s (AHN) string of ... the fifth consecutive year, AHN earned more honors than any health care provider in ... a dinner Sept. 14 at the Omni William Penn Hotel in downtown Pittsburgh included:, ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... INDIANAPOLIS , Sept. 7, 2017  Eli ... today announced actions to streamline operations to more ... to improve its cost structure. Global workforce reductions, ... program, are expected to impact approximately 3,500 positions. ... the company expects annualized savings of approximately $500 ...
(Date:9/7/2017)... 2017   BioLife Solutions , Inc. (NASDAQ: ... clinical grade cell and tissue hypothermic storage and ... Rice , President and CEO, will be presenting at two ... & Renshaw 19 th Annual Global Investment Conference on ... Pacific time). The conference is being held at the New ...
(Date:9/6/2017)... 6, 2017 Eli Lilly and Company (NYSE: ... new data for galcanezumab and lasmiditan, two investigational treatments ... Headache Society (IHC) taking place Sept. 7-10 in ... highlight new, long-term data from an open-label study evaluating ... (120 mg and 240 mg) for the prevention of ...
Breaking Medicine Technology: